4.7 Review

Decoding competing endogenous RNA networks for cancer biomarker discovery

期刊

BRIEFINGS IN BIOINFORMATICS
卷 21, 期 2, 页码 441-457

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbz006

关键词

ceRNA interaction; network reconstruction and characterization; biomarker discovery; cancer pathogenesis and management

资金

  1. National Key Research AMP
  2. Development Program of China [2016YFC1306605]
  3. National Natural Science Foundation of China [31670851, 31470821, 91530320, 31770903, 31600670]
  4. Jiangsu Planned Projects for Postdoctoral Research Funds [2018K173C]

向作者/读者索取更多资源

Crosstalk between competing endogenous RNAs (ceRNAs) is mediated by shared microRNAs (miRNAs) and plays important roles both in normal physiology and tumorigenesis; thus, it is attractive for systems-level decoding of gene regulation. As ceRNA networks link the function of miRNAs with that of transcripts sharing the same miRNA response elements (MREs), e.g. pseudogenes, competing mRNAs, long non-coding RNAs, and circular RNAs, the perturbation of crucial interactions in ceRNA networks may contribute to carcinogenesis by affecting the balance of cellular regulatory system. Therefore, discovering biomarkers that indicate cancer initiation, development, and/or therapeutic responses via reconstructing and analyzing ceRNA networks is of clinical significance. In this review, the regulatory function of ceRNAs in cancer and crucial determinants of ceRNA crosstalk are firstly discussed to gain a global understanding of ceRNA-mediated carcinogenesis. Then, computational and experimental approaches for ceRNA network reconstruction and ceRNA validation, respectively, are described from a systems biology perspective. We focus on strategies for biomarker identification based on analyzing ceRNA networks and highlight the translational applications of ceRNA biomarkers for cancer management. This article will shed light on the significance of miRNA-mediated ceRNA interactions and provide important clues for discovering ceRNA network-based biomarker in cancer biology, thereby accelerating the pace of precision medicine and healthcare for cancer patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据